why choose us

First received: August 14, 2023

Clinical Trial: Psilocybin in Cancer Pain Study

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Opioid-Related Disorders

Study Type: INTERVENTIONAL


Official Title: Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer

Brief Summary: The overall objective of this study is to assess the feasibility, safety and preliminary efficacy of psilocybin-assisted therapy to alleviate opioid-refractory pain in patients with advanced-cancer.The name of the study intervention used in this research study is:Psilocybin (a tryptamine derivative)

Read more